Gilead Sciences has opened a 182,000-square-foot research center at its Foster City headquarters, expanding capabilities in oncology, inflammation and research data science to advance medicines for some of the world’s most challenging diseases. The new research center builds on Gilead's longstanding presence in California.

Daniel O'Day, Chairman and CEO, Gilead Sciences, said, “We are in a moment of unprecedented opportunity in science and technology. Our new research center will help Gilead scientists make the most of that opportunity, delivering more breakthrough medicines faster. As part of our broader USD 32 billion investment in the United States, this new facility also reflects our long-term commitment to American innovation."

The research center is 1 of 3 major Foster City projects advancing Gilead’s broader US investment in research, development and manufacturing through 2030. The technical development center, expected to open in 2027, and the biologics facility, which broke ground in August and is expected to open in 2029, will further strengthen Gilead’s US research and development infrastructure.

Flavius Martin, MD and EVP, Research, Gilead Sciences, said, “The future of biomedical innovation depends on bringing together exceptional science, advanced technologies and diverse expertise. This center was designed to do exactly that. By co-locating key research disciplines and expanding our data science capabilities, we are strengthening the infrastructure needed to accelerate discovery and advance meaningful innovations.”

Designed with input from Gilead research colleagues, the 5-story center will support approximately 325 employees, including 260 laboratory scientists. Flexible laboratory neighborhoods, specialised collaboration spaces and shared technology platforms will enable teams to adapt as scientific needs evolve. All-electric systems, energy-efficient design and water-saving landscaping featuring California native plants are expected to support LEED Gold certification.

Kevin Mullin, US Representative for California’s 15th Congressional District, said, “Foster City is home to some of the most important biomedical research happening anywhere in the world, and Gilead’s continued investment here is a vote of confidence in California’s life sciences workforce. The new center expands Gilead’s research capacity in Foster City, supporting the region’s biotechnology leadership and skilled workforce.”

A dedicated bridge to an adjacent building streamlines the transfer of equipment and research materials, while the new research quad provides a central gathering space for collaboration and scientific exchange.

Diane Papan, California State Assembly member, 21st District, said, “San Mateo County is one of the most important and vital biotechnology centers in the world. Gilead’s sustained support for science, infrastructure and skilled jobs only strengthens our position.”